Organogenesis logo

Organogenesis

ORGO | NASDAQ
Chart Builder DCF Calculator
$0.80
-$0.01 (-1.25%)
At close: Nov 16, 2026, 4:00 PM ET
$0.80
$0.00 (+0.39%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.25%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #689/1021 (Top 67%)

Key Statistics

Market Data

Market Cap $104.24M
1D Range
0.78 0.83
52W Range
0.76 5.99

Valuation (TTM)

PE -0.67
PB 0.87
EV/EBITDA -2.48

Valuation (NTM)

Forward PE 8.55
Forward PEG 0.00
Price Target $2.50
Loading financial charts...

Profile

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical an...

Sector Healthcare
Employees 854
IPO Date Jan 5, 2017
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.25
Miss -42.86%
REV
$45.5M
Miss -12.67%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$2.50
Upside
+212.50%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.